Common Contracts
8 similar Executive Agreement contracts by ContraVir Pharmaceuticals, Inc., Aditx Therapeutics, Inc., Amesite Inc., others
EXECUTIVE AGREEMENTExecutive Agreement • February 26th, 2021 • Aditx Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Executive Agreement (the “Agreement”) is made and entered into effective as of February 24, 2021 (the “Effective Date”), by and between Amro Albanna (the “Executive”) and Aditx Therapeutics, Inc., a Delaware corporation (the “Company”).
EXECUTIVE AGREEMENTExecutive Agreement • September 4th, 2020 • Amesite Operating Co • Services-prepackaged software • Delaware
This Executive Agreement (the “Agreement”) is made and entered into effective as of June 1, 2020 (the “Effective Date”), by and between Ann Marie Sastry (the “Executive”) and Amesite, Inc., a Delaware corporation (the “Company”).
EXECUTIVE AGREEMENTExecutive Agreement • June 9th, 2020 • Amesite Inc. • Services-prepackaged software • Delaware
This Executive Agreement (the “Agreement”) is made and entered into effective as of June 1, 2020 (the “Effective Date”), by and between Ann Marie Sastry (the “Executive”) and Amesite, Inc., a Delaware corporation (the “Company”).
EXECUTIVE AGREEMENTExecutive Agreement • February 12th, 2018 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • Connecticut
This Executive Agreement (the “Agreement”) is made and entered into effective as of September 1, 2014 (the “Effective Date”), by and between Vimal Mehta (the “Executive”) and BioXcel Corporation., a Delaware corporation (the “Company”).
EXECUTIVE AGREEMENTExecutive Agreement • January 15th, 2015 • ContraVir Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This Executive Agreement (the “Agreement”) is made and entered into effective as of January 19, 2015 (the “Effective Date”), by and between Dr. John Sullivan-Bolyai (the “Executive”) and ContraVir Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
EXECUTIVE AGREEMENTExecutive Agreement • June 26th, 2014 • ContraVir Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Executive Agreement (the “Agreement”) is made and entered into effective as of June 23, 2014 (the “Effective Date”), by and between William Hornung (the “Executive”) and ContraVir Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
EXECUTIVE AGREEMENTExecutive Agreement • March 20th, 2014 • ContraVir Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Executive Agreement (the “Agreement”) is made and entered into effective as of March 19, 2014 (the “Effective Date”), by and between James Sapirstein (the “Executive”) and ContraVir Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
EXECUTIVE AGREEMENTExecutive Agreement • February 15th, 2012 • TrovaGene Inc. • Biological products, (no disgnostic substances) • California
This Executive Agreement (the “Agreement”) is made and entered into effective as of February 1, 2012 (the “Effective Date”), by and between Steve Zaniboni (the “Executive”) and TrovaGene, Inc., a Delaware corporation (the “Company”).
